Open AccessDuration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910
Author(s) -
Thomas M. Pisansky,
Daniel Hunt,
Leonard G. Gomella,
Mahul B. Amin,
Alexander G. Balogh,
Daniel M. Chinn,
Michael J. Seider,
Marie Duclos,
Seth A. Rosenthal,
Glenn Bauman,
Elizabeth Gore,
Marvin Rotman,
Himanshu Lukka,
William U. Shipley,
James J. Dignam,
Howard M. Sandler
Publication year - 2014
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2014.58.0662
Subject(s) - medicine , prostate cancer , hazard ratio , radiation therapy , androgen suppression , randomized controlled trial , urology , cancer , prostate , surgery , confidence interval
To determine whether prolonged androgen suppression (AS) duration before radiotherapy improves survival and disease control in prostate cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom